Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Meeting Demand for Biologics: The Bioprocessing Summit Explores Today's Challenges and Tomorrow's Advances


To meet exploding demand for biological drugs that can cure fatal diseases, counter chemical threats, or fight cancer, the bioprocessing industry is evolving to "digital biomanufacturing"? capitalizing on innovations like predictive analytics to fast track their protein-based therapies.

From August 12-16, 2019, more than 1,500 scientists, engineers and leaders from this international community will unite at The Bioprocessing Summit in Boston to explore the transformation ahead. They will also share new solutions to the challenges they encounter today, as they work to maximize quality, safety and cost-efficiency in the biologics manufacturing process.

"Distinguished by its high-caliber scientific content, the eleventh annual Bioprocessing Summit will offer abundant opportunities to access new data, case studies, technologies and techniques, and initiate valuable collaborations," said Mary Ruberry, Senior Conference Director, Cambridge Healthtech Institute, which produces this event.

This year's Plenary Keynote Sessions will focus on current challenges and future innovations:

Leading to Tomorrow's Advances (August 12)

Solving Today's Challenges (August 14)

The Bioprocessing Summit will include 200+ presentations on upstream and downstream processing, analytical and quality, formulation and stability, cell and gene therapy, manufacturing, and more.

In addition to one-on-one networking, an Exhibit Hall with 110+ cutting-edge innovators, and 80+ poster sessions, the conference will feature training seminars, special events sponsored by the International Society for Cell and Gene Therapy (ISCT), Women in Bio (WIB) and The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), breakout discussions and short courses.

Please see bioprocessingsummit.com.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT WorldClinical Research News and Diagnostics World.


These press releases may also interest you

at 09:41
World Federation of Neurology ? For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During the XXIV World Congress of Neurology (WCN 2019)  in Dubai, UAE, which took place Oct. 27-31, 2019,...

at 09:35
Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that UnitedHealthcare®, the largest commercial insurer in the United States, has lifted coverage restrictions on endobronchial valves, a minimally-invasive...

at 09:33
Jonas Fitness, the industry leader in Club Management Software, was announced last week as the 2019 Medical Fitness Association's Industry Partner of the Year at their 19th annual International Conference. "We are so...

at 09:33
The next generation of the award-winning FreeStyle® Comfort® portable oxygen concentrator will be the highlight of the CAIRE Inc. stand at the MEDICA show 18-21 November at the Dusseldorf Exhibition Centre in Germany. Originally introduced in 2018,...

at 09:32
Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of ?2.1 million in funding from the EU's Horizon 2020 program. The EU grant was awarded to support Aiforia's ongoing development work of...

at 09:30
TOMI Environmental Solutions, Inc.® ("TOMI") , a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization Technology® (BITtm) platform through the manufacturing, licensing, servicing, and selling of its...



News published on 12 june 2019 at 10:25 and distributed by: